Abivax S.A. SEC filings AAVXF
Abivax S.A. has 105 filings in SEC EDGAR's recent list, going back to Dec 16, 2022. Its latest annual report, Form 20-F, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 21, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 21, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 2, 2026 | Jul 2, 2026 |
| 6-K | Current report (foreign issuer) | Jun 29, 2026 | Jun 29, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 1, 2026 |
| 6-K | Current report (foreign issuer) | May 22, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | May 20, 2026 | May 20, 2026 |
| 6-K | Current report (foreign issuer) | May 7, 2026 | May 7, 2026 |
| 6-K | Current report (foreign issuer) | Apr 20, 2026 | Apr 20, 2026 |
| 6-K | Current report (foreign issuer) | Mar 23, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Feb 23, 2026 | Feb 21, 2026 |
| 6-K | Current report (foreign issuer) | Dec 15, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Sep 8, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jul 24, 2025 | Jul 24, 2025 |
| 6-K | Current report (foreign issuer) | Jul 22, 2025 | Jul 22, 2025 |
| 6-K | Current report (foreign issuer) | Jun 11, 2025 | Jun 11, 2025 |
| 6-K | Current report (foreign issuer) | Jun 2, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Apr 29, 2025 | Apr 29, 2025 |
| 6-K | Current report (foreign issuer) | Apr 22, 2025 | Apr 22, 2025 |
| 6-K | Current report (foreign issuer) | Mar 24, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Jan 10, 2025 | Jan 10, 2025 |
| 6-K | Current report (foreign issuer) | Dec 23, 2024 | Dec 23, 2024 |
| 6-K | Current report (foreign issuer) | Nov 19, 2024 | Nov 19, 2024 |
| 6-K | Current report (foreign issuer) | Nov 14, 2024 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Oct 3, 2024 | Oct 3, 2024 |
| 6-K | Current report (foreign issuer) | Oct 3, 2024 | Oct 3, 2024 |
| 6-K | Current report (foreign issuer) | Sep 26, 2024 | Sep 26, 2024 |
| 6-K | Current report (foreign issuer) | Sep 25, 2024 | Sep 25, 2024 |
| 6-K | Current report (foreign issuer) | Sep 9, 2024 | Sep 9, 2024 |
| 6-K | Current report (foreign issuer) | Sep 9, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 6, 2024 | Aug 6, 2024 |
| 6-K | Current report (foreign issuer) | Jul 16, 2024 | Jul 15, 2024 |
| 6-K | Current report (foreign issuer) | Jun 4, 2024 | Jun 4, 2024 |
| 6-K | Current report (foreign issuer) | May 7, 2024 | May 7, 2024 |
| 6-K | Current report (foreign issuer) | Apr 2, 2024 | Apr 2, 2024 |
| 6-K | Current report (foreign issuer) | Feb 2, 2024 | Feb 2, 2024 |
| 6-K | Current report (foreign issuer) | Jan 22, 2024 | Jan 22, 2024 |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABVX (Nasdaq), AAVXF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Paris
- SEC filer status
- Accelerated filer, Emerging growth company
- SEC CIK
- 1956827
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.